BioXcel Therapeutics, Inc. Quarterly Quick Ratio in % from Q4 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary: BioXcel Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q4 2022 to Q3 2024.
BioXcel Therapeutics, Inc. Quick Ratio for the quarter ending September 30, 2024 was 7.74 %, a 33.4% increase year-over-year.

Quick Ratio, Quarterly (%)

Quick Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	7.74	+1.94	+33.4%	Sep 30, 2024
Q2 2024	7.28	+1.21	+19.9%	Jun 30, 2024
Q1 2024	6.3	-0.12	-1.87%	Mar 31, 2024
Q4 2023	6.06	+0.13	+2.19%	Dec 31, 2023
Q3 2023	5.8			Sep 30, 2023
Q2 2023	6.07			Jun 30, 2023
Q1 2023	6.42			Mar 31, 2023
Q4 2022	5.93			Dec 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.